China Regenerative Medicine International Limited

HK$0.24As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8158Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (40.53%)
Div yield —
ROE 64.18%
Biotechnology
Beta (5Y) (0.92)
PE TTM 2.652
TSR TTM (61.90%)
Mkt cap HK$73.02M
ROIC 97.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.251
4.47%
173.00%
Hold 9|9|11|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
3.42%
3.87%
1.70%
12.52%
Revenue$M
9.209
9.500
9.531
9.539
2.79%
5.25%
(0.32%)
2.62%
Peers (US$9.314M)
Cap (US$)
PE
31.89M
—
Capital
TTM
5Y
10Y
Leveragex
0.684
(0.081)
(0.075)
EBIT/Intx
0.306
0.859
0.809
Own earn%
132.85
(191.32)
(177.15)
Sh yield%
28.24
25.24
26.85
Owners
Insiders/Inst%
0.74
59.87
Short interest%
5.50
SBC / revenue%
3.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
68